Lombard Medical Technologies PLC (LMT) is a medical technology company. The Company�s principal activities are the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through its own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. LMT�s Aorfix product is the endovascular stent graft for patients with tortuous vascular anatomy. Aorfix combines a design and technology that result in clinical performance in endovascular aortic repair (EVAR) patients with complex anatomy. The product is used to treat complex aneurysms up to 90 degrees. Aorfix includes nitinol rings and a helical scaffold covered by a woven polyester fabric. LMT�s subsidiaries include Lombard Medical Limited, PolyBioMed Limited, LionMedical Limited, Lombard Medical Technologies Inc Lombard Medical Scotland Limited.